Lineage Cell Therapeutics (LCTX)
Lineage Cell Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on NYSE, classified by the SEC as biological products, (no diagnostic substances).
25.9M
Short interest
settlement 2026-10-15
16.8
Days to cover
+1.0 days vs prior
62.2%
Short share of volume
2026-11-02
26,826
Fails to deliver
settlement 2026-10-14
Thu 5 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in LCTX is 25,927,289 shares, down 3,541,362 shares over the last month. Over the last 48 readings it ranged from 15,938,784 shares (31 October 2024) to 33,795,581 shares (31 October 2025). At the reported average volume of 1.5M shares a day that is 16.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/lctx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 25,927,289 | -10.9% | 1,545,380 | 16.78 |
| 2026-09-30 | 29,093,018 | -1.3% | 1,846,827 | 15.75 |
| 2026-09-15 | 29,468,651 | +1.7% | 1,106,216 | 26.64 |
| 2026-08-31 | 28,983,004 | +2.3% | 876,205 | 33.08 |
| 2026-08-14 | 28,331,489 | -4.2% | 808,109 | 35.06 |
| 2026-07-31 | 29,561,507 | -1.0% | 1,128,474 | 26.20 |
| 2026-07-15 | 29,867,928 | +6.0% | 862,087 | 34.65 |
| 2026-06-30 | 28,185,804 | +10.3% | 3,379,386 | 8.34 |
| 2026-06-15 | 25,555,170 | -2.0% | 1,109,741 | 23.03 |
| 2026-05-29 | 26,083,430 | +0.7% | 1,045,038 | 24.96 |
| 2026-05-15 | 25,915,824 | +1.3% | 1,546,127 | 16.76 |
| 2026-04-30 | 25,584,679 | +1.1% | 1,177,565 | 21.73 |
| 2026-04-15 | 25,292,784 | -0.7% | 1,024,681 | 24.68 |
| 2026-03-31 | 25,474,080 | +0.0% | 1,140,591 | 22.33 |
| 2026-03-13 | 25,466,565 | +1.6% | 1,384,437 | 18.39 |
| 2026-02-27 | 25,052,389 | -0.6% | 962,049 | 26.04 |
| 2026-02-13 | 25,194,839 | -0.6% | 1,402,485 | 17.96 |
| 2026-01-30 | 25,348,081 | +1.0% | 1,013,022 | 25.02 |
| 2026-01-15 | 25,102,567 | +1.9% | 1,048,897 | 23.93 |
| 2025-12-31 | 24,635,130 | +3.9% | 1,396,602 | 17.64 |
| 2025-12-15 | 23,708,947 | +3.8% | 1,192,134 | 19.89 |
| 2025-11-28 | 22,837,063 | +1.1% | 1,436,643 | 15.90 |
| 2025-11-14 | 22,579,627 | -33.2% | 3,311,884 | 6.82 |
| 2025-10-31 | 33,795,581 | +6.4% | 1,812,196 | 18.65 |
| 2025-10-15 | 31,772,044 | +9.5% | 1,785,615 | 17.79 |
| 2025-09-30 | 29,010,613 | +4.5% | 1,925,012 | 15.07 |
| 2025-09-15 | 27,748,083 | +2.6% | 1,312,770 | 21.14 |
| 2025-08-29 | 27,048,226 | +1.1% | 1,349,582 | 20.04 |
| 2025-08-15 | 26,758,520 | -1.8% | 1,649,868 | 16.22 |
| 2025-07-31 | 27,236,726 | -3.0% | 1,713,119 | 15.90 |
| 2025-07-15 | 28,094,805 | +1.3% | 1,737,255 | 16.17 |
| 2025-06-30 | 27,739,415 | -3.4% | 6,499,752 | 4.27 |
| 2025-06-13 | 28,728,210 | -2.3% | 2,227,109 | 12.90 |
| 2025-05-30 | 29,410,740 | -1.9% | 1,328,090 | 22.15 |
| 2025-05-15 | 29,963,709 | -0.1% | 747,329 | 40.09 |
| 2025-04-30 | 30,003,557 | +5.5% | 1,108,986 | 27.05 |
| 2025-04-15 | 28,432,912 | +6.7% | 1,325,716 | 21.45 |
| 2025-03-31 | 26,641,663 | +19.2% | 2,119,500 | 12.57 |
| 2025-03-14 | 22,344,067 | +1.4% | 1,522,245 | 14.68 |
| 2025-02-28 | 22,027,996 | +2.2% | 929,120 | 23.71 |
| 2025-02-14 | 21,552,750 | +1.2% | 1,318,175 | 16.35 |
| 2025-01-31 | 21,298,495 | -21.4% | 1,823,637 | 11.68 |
| 2025-01-15 | 27,108,540 | +4.2% | 3,126,522 | 8.67 |
| 2024-12-31 | 26,026,548 | +13.4% | 1,928,522 | 13.50 |
| 2024-12-13 | 22,941,736 | +25.1% | 2,895,143 | 7.92 |
| 2024-11-29 | 18,342,791 | +13.7% | 5,825,617 | 3.15 |
| 2024-11-15 | 16,133,922 | +1.2% | 514,684 | 31.35 |
| 2024-10-31 | 15,938,784 | +1.1% | 447,257 | 35.64 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of LCTX volume is 62.2%, down 16.5 points over the last five sessions. Over the last 30 readings it ranged from 39.8% (29 September 2026) to 78.6% (26 October 2026). The latest reading is 4.1 points below the 30-session average of 66.3%, on 1.2M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 736K | 1.2M | 62.2% | 5,000 |
| 2026-10-30 | 493K | 680K | 72.6% | 0 |
| 2026-10-29 | 387K | 587K | 65.9% | 14,872 |
| 2026-10-28 | 436K | 600K | 72.7% | 34,145 |
| 2026-10-27 | 287K | 588K | 48.8% | 0 |
| 2026-10-26 | 1.0M | 1.3M | 78.6% | 0 |
| 2026-10-23 | 534K | 682K | 78.2% | 5 |
| 2026-10-22 | 442K | 602K | 73.4% | 19,500 |
| 2026-10-21 | 601K | 804K | 74.8% | 43,400 |
| 2026-10-20 | 715K | 1.1M | 66.6% | 0 |
| 2026-10-19 | 483K | 628K | 76.9% | 0 |
| 2026-10-16 | 561K | 755K | 74.3% | 4,870 |
| 2026-10-15 | 599K | 936K | 64.0% | 3,229 |
| 2026-10-14 | 881K | 1.4M | 62.1% | 0 |
| 2026-10-13 | 746K | 1.2M | 62.0% | 3,000 |
| 2026-10-12 | 693K | 1.3M | 53.7% | 4,849 |
| 2026-10-09 | 367K | 631K | 58.1% | 0 |
| 2026-10-08 | 604K | 840K | 71.9% | 390 |
| 2026-10-07 | 575K | 993K | 57.9% | 0 |
| 2026-10-06 | 392K | 624K | 62.9% | 17 |
| 2026-10-05 | 555K | 730K | 76.0% | 0 |
| 2026-10-02 | 507K | 670K | 75.7% | 0 |
| 2026-10-01 | 583K | 886K | 65.8% | 700 |
| 2026-09-30 | 317K | 533K | 59.5% | 45 |
| 2026-09-29 | 542K | 1.4M | 39.8% | 25 |
| 2026-09-28 | 611K | 838K | 72.8% | 43,690 |
| 2026-09-25 | 1.1M | 1.5M | 76.1% | 2,000 |
| 2026-09-24 | 804K | 1.3M | 62.7% | 11,113 |
| 2026-09-23 | 822K | 1.5M | 53.8% | 0 |
| 2026-09-22 | 304K | 449K | 67.8% | 16,072 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in LCTX is 26,826 shares, up 17,385 shares over the last settlement date. Over the last 30 readings it ranged from 10 shares (3 September 2026) to 43,612 shares (4 August 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 26,826 | $0.91 | $24K |
| 2026-10-09 | 9,441 | $1.03 | $10K |
| 2026-10-02 | 5,939 | $0.90 | $5K |
| 2026-10-01 | 599 | $0.96 | $575 |
| 2026-09-29 | 8,789 | $0.97 | $9K |
| 2026-09-21 | 13,413 | $1.03 | $14K |
| 2026-09-18 | 311 | $1.03 | $320 |
| 2026-09-17 | 1,968 | $1.07 | $2K |
| 2026-09-16 | 1,968 | $1.06 | $2K |
| 2026-09-11 | 187 | $1.02 | $191 |
| 2026-09-10 | 1,817 | $1.03 | $2K |
| 2026-09-03 | 10 | $1.11 | $11 |
| 2026-09-02 | 775 | $1.08 | $837 |
| 2026-08-27 | 15,053 | $1.12 | $17K |
| 2026-08-21 | 53 | $1.08 | $57 |
| 2026-08-20 | 14 | $1.10 | $15 |
| 2026-08-12 | 205 | $1.12 | $230 |
| 2026-08-11 | 376 | $1.13 | $425 |
| 2026-08-10 | 284 | $1.10 | $312 |
| 2026-08-07 | 116 | $1.13 | $131 |
| 2026-08-04 | 43,612 | $1.11 | $48K |
| 2026-08-03 | 18 | $1.08 | $19 |
| 2026-07-31 | 68 | $1.11 | $75 |
| 2026-07-30 | 2,027 | $1.06 | $2K |
| 2026-07-29 | 666 | $1.07 | $713 |
| 2026-07-21 | 569 | $1.10 | $626 |
| 2026-07-17 | 7,768 | $1.17 | $9K |
| 2026-07-01 | 2,698 | $1.31 | $4K |
| 2026-06-30 | 14,119 | $1.35 | $19K |
| 2026-06-25 | 154 | $1.26 | $194 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for LCTX in the last 90 days. The most recent filings are listed below. Latest filing: Culley Brian M (President and CEO) on 2026-03-12.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-03-12 | Culley Brian M | President and CEO | Buy | 15K | $1.63 | $24K | 256K |
| 2026-02-11 | Samuel George A. III | General Counsel and Secretary | Tax withholding | 3K | $1.80 | $5K | 31K |
| 2026-02-11 | Samuel George A. III | General Counsel and Secretary | Exercise or conversion | 6K | price not stated in the filing | not stated | 34K |
| 2026-02-11 | Culley Brian M | President and CEO | Tax withholding | 13K | $1.80 | $23K | 241K |
| 2026-02-11 | Culley Brian M | President and CEO | Exercise or conversion | 31K | price not stated in the filing | not stated | 253K |
| 2025-12-19 | Samuel George A. III | General Counsel and Secretary | Tax withholding | 65 | $1.68 | $109 | 27K |
| 2025-12-19 | Samuel George A. III | General Counsel and Secretary | Grant | 2K | price not stated in the filing | not stated | 28K |
| 2025-12-19 | Culley Brian M | President and CEO | Tax withholding | 334 | $1.68 | $561 | 222K |
| 2025-12-19 | Culley Brian M | President and CEO | Grant | 9K | price not stated in the filing | not stated | 222K |
| 2025-02-11 | Culley Brian M | President and CEO | Tax withholding | 13K | $0.65 | $8K | 214K |
| 2025-02-11 | Culley Brian M | President and CEO | Exercise or conversion | 31K | price not stated in the filing | not stated | 226K |
| 2025-02-11 | Samuel George A. III | General Counsel | Tax withholding | 2K | $0.65 | $2K | 26K |
| 2025-02-11 | Samuel George A. III | General Counsel | Exercise or conversion | 6K | price not stated in the filing | not stated | 28K |
| 2025-01-27 | BROADWOOD CAPITAL INC | TenPercentOwner | Buy | 0 | $0.00 | $0 | 49.6M |
| 2025-01-27 | BROADWOOD CAPITAL INC | TenPercentOwner | Buy | 7.9M | $0.76 | $6.0M | 49.6M |
| 2024-11-26 | Samuel George A. III | General Counsel | Buy | 15K | $0.60 | $9K | 22K |
| 2024-11-26 | Howe Jill Ann | Chief Financial Officer | Buy | 15K | $0.59 | $9K | 26K |
| 2024-11-22 | Mulroy Michael H. | Director | Buy | 40K | $0.57 | $23K | 299K |
| 2024-11-21 | Culley Brian M | President and CEO | Buy | 40K | $0.60 | $24K | 195K |
| 2024-08-16 | Howe Jill Ann | Chief Financial Officer | Buy | 11K | $0.89 | $9K | 11K |
| 2024-05-24 | Culley Brian M | President and CEO | Buy | 10K | $1.05 | $11K | 155K |
| 2024-02-11 | Culley Brian M | President and CEO | Tax withholding | 13K | $1.08 | $14K | 145K |
| 2024-02-11 | Culley Brian M | President and CEO | Exercise or conversion | 31K | price not stated in the filing | not stated | 158K |
| 2024-02-11 | Samuel George A. III | General Counsel/Secretary | Tax withholding | 2K | $1.08 | $3K | 7K |
| 2024-02-11 | Samuel George A. III | General Counsel/Secretary | Exercise or conversion | 6K | price not stated in the filing | not stated | 10K |
| 2024-02-08 | BAILEY DON M | Director | Buy | 96K | $1.04 | $100K | 159K |
| 2024-02-06 | BROADWOOD PARTNERS, L.P. | Director,TenPercentOwner | Buy | 6.7M | $1.04 | $7.0M | 41.7M |
| 2024-02-06 | BROADWOOD PARTNERS, L.P. | Director,TenPercentOwner | Buy | 0 | $0.00 | $0 | 41.7M |
| 2023-12-29 | Jayasuriya Anula | Director | Buy | 10K | $1.09 | $11K | 10K |
| 2023-02-11 | Culley Brian M | President and CEO | Tax withholding | 13K | $1.35 | $17K | 126K |
| 2023-02-11 | Culley Brian M | President and CEO | Exercise or conversion | 31K | price not stated in the filing | not stated | 139K |
| 2023-02-11 | Samuel George A. III | General Counsel/Secretary | Tax withholding | 2K | $1.35 | $3K | 4K |
| 2023-02-11 | Samuel George A. III | General Counsel/Secretary | Exercise or conversion | 6K | price not stated in the filing | not stated | 6K |
| 2023-02-11 | Hogge Gary S. | SVP,Clinical & Medical Affairs | Tax withholding | 5K | $1.35 | $7K | 8K |
| 2023-02-11 | Hogge Gary S. | SVP,Clinical & Medical Affairs | Exercise or conversion | 13K | price not stated in the filing | not stated | 13K |
| 2022-06-30 | Culley Brian M | President and CEO | Tax withholding | 5K | $1.58 | $8K | 108K |
| 2022-06-30 | Culley Brian M | President and CEO | Exercise or conversion | 15K | price not stated in the filing | not stated | 113K |
| 2022-03-31 | Culley Brian M | President and CEO | Exercise or conversion | 15K | price not stated in the filing | not stated | 97K |
| 2022-03-31 | Culley Brian M | President and CEO | Tax withholding | 5K | $1.54 | $8K | 91K |
| 2022-03-31 | Culley Brian M | President and CEO | Buy | 6K | $1.53 | $10K | 98K |
| 2022-03-28 | Amin Dipti | Director | Buy | 35K | $1.63 | $57K | 35K |
| 2022-03-25 | BRADSHER NEAL C | Director,TenPercentOwner | Buy | 0 | $0.00 | $0 | 34.9M |
| 2022-03-25 | BRADSHER NEAL C | Director,TenPercentOwner | Buy | 470K | $1.44 | $677K | 34.9M |
| 2022-03-25 | Culley Brian M | President and CEO | Buy | 5K | $1.38 | $7K | 81K |
| 2022-03-24 | Mulroy Michael H. | Director | Buy | 7K | $1.40 | $10K | 259K |
| 2022-03-24 | BRADSHER NEAL C | Director,TenPercentOwner | Buy | 0 | $0.00 | $0 | 34.5M |
| 2022-03-24 | BRADSHER NEAL C | Director,TenPercentOwner | Buy | 200K | $1.42 | $284K | 34.5M |
| 2022-03-23 | BRADSHER NEAL C | Director,TenPercentOwner | Buy | 260K | $1.37 | $356K | 34.3M |
| 2022-03-23 | BRADSHER NEAL C | Director,TenPercentOwner | Buy | 0 | $0.00 | $0 | 34.3M |
| 2021-12-31 | Culley Brian M | President and CEO | Tax withholding | 5K | $2.45 | $13K | 76K |
| 2021-12-31 | Culley Brian M | President and CEO | Exercise or conversion | 15K | price not stated in the filing | not stated | 81K |
| 2021-12-29 | Hogge Gary S. | SVP,Clinical & Medical Affairs | Sell | 28K | $2.44 | $69K | 0 |
| 2021-12-29 | Hogge Gary S. | SVP,Clinical & Medical Affairs | Sell | 9K | $2.49 | $23K | 28K |
| 2021-12-29 | Hogge Gary S. | SVP,Clinical & Medical Affairs | Exercise or conversion | 9K | $0.69 | $6K | 38K |
| 2021-12-28 | Hogge Gary S. | SVP,Clinical & Medical Affairs | Sell | 502K | $2.45 | $1.2M | 28K |
| 2021-12-28 | Hogge Gary S. | SVP,Clinical & Medical Affairs | Exercise or conversion | 80K | $1.14 | $91K | 530K |
| 2021-12-28 | Hogge Gary S. | SVP,Clinical & Medical Affairs | Exercise or conversion | 237K | $2.11 | $500K | 450K |
| 2021-12-28 | Hogge Gary S. | SVP,Clinical & Medical Affairs | Exercise or conversion | 185K | $0.69 | $128K | 213K |
| 2021-09-30 | Culley Brian M | President and CEO | Exercise or conversion | 15K | price not stated in the filing | not stated | 71K |
| 2021-09-30 | Culley Brian M | President and CEO | Tax withholding | 5K | $2.52 | $13K | 66K |
| 2021-06-30 | Culley Brian M | President and CEO | Exercise or conversion | 15K | $2.85 | $44K | 61K |
| 2021-06-30 | Culley Brian M | President and CEO | Tax withholding | 5K | $2.85 | $15K | 56K |
| 2021-06-29 | Russell Angus C. | Director | Exercise or conversion | 25K | $2.20 | $54K | 92K |
| 2021-06-29 | Russell Angus C. | Director | Sell | 5K | $2.97 | $14K | 88K |
| 2021-06-29 | ANDREWS DEBORAH J | Director | Exercise or conversion | 25K | $2.20 | $54K | 35K |
| 2021-06-29 | ANDREWS DEBORAH J | Director | Sell | 19K | $2.93 | $56K | 16K |
| 2021-06-28 | Culley Brian M | President and CEO | Sell | 450K | $2.87 | $1.3M | 46K |
| 2021-06-28 | Culley Brian M | President and CEO | Exercise or conversion | 300K | $0.69 | $207K | 496K |
| 2021-06-25 | BRADSHER NEAL C | Director,TenPercentOwner | Exercise or conversion | 25K | $2.20 | $54K | 88K |
| 2021-06-22 | KINGSLEY ALFRED D | Director | Exercise or conversion | 62K | $2.20 | $136K | 5.5M |
| 2021-06-18 | Mulroy Michael H. | Director | Exercise or conversion | 25K | $2.20 | $54K | 252K |
| 2021-03-31 | Culley Brian M | President and CEO | Exercise or conversion | 15K | $2.35 | $36K | 201K |
| 2021-03-31 | Culley Brian M | President and CEO | Tax withholding | 5K | $2.35 | $13K | 196K |
| 2021-03-30 | Hernandez Alexandra | Sr Director Finance/Controller | Exercise or conversion | 6K | $0.69 | $4K | 6K |
| 2021-03-30 | Hernandez Alexandra | Sr Director Finance/Controller | Sell | 6K | $2.23 | $13K | 0 |
| 2020-12-31 | Culley Brian M | President and CEO | Exercise or conversion | 15K | $1.76 | $27K | 191K |
| 2020-12-31 | Culley Brian M | President and CEO | Tax withholding | 5K | $1.76 | $9K | 186K |
| 2020-09-30 | Culley Brian M | President and CEO | Tax withholding | 5K | $0.94 | $5K | 175K |
| 2020-09-30 | Culley Brian M | President and CEO | Exercise or conversion | 15K | $0.94 | $15K | 181K |
| 2020-06-30 | Culley Brian M | President and CEO | Exercise or conversion | 15K | $0.87 | $13K | 171K |
| 2020-06-30 | Culley Brian M | President and CEO | Tax withholding | 5K | $0.87 | $5K | 165K |
| 2020-03-31 | Culley Brian M | President and CEO | Exercise or conversion | 15K | $0.83 | $13K | 161K |
| 2020-03-31 | Culley Brian M | President and CEO | Tax withholding | 5K | $0.83 | $4K | 155K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for LCTX worth $96K at the prices reported; 0 in the last 90 days worth $0. Latest: DON M BAILEY filed on 2025-09-24 to sell 60,000 shares ($96K) from 2025-09-24.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2025-09-24 | DON M BAILEYDirector | 60K | $96K | 0.026% | 2025-09-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON5 holders report 5% or more of LCTX in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is NEAL C. BRADSHER at 23.1% of the class (57,848,357 shares), filed 2025-11-14 for an event on 2025-11-12.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-07-29 | 13G | BlackRock, Inc.parent holding company | 13.2M | 5.3% | 2026-06-30 |
| 2025-11-14 | 13D/Ano. 29 | NEAL C. BRADSHERindividual, parent holding company | 57.8M | 23.1% | 2025-11-12 |
| 2025-11-14 | 13D/Ano. 29 | BROADWOOD PARTNERS, L.P.partnership | 57.5M | 23.0% | 2025-11-12 |
| 2025-11-14 | 13D/Ano. 29 | BROADWOOD CAPITAL, INC.corporation, investment adviser | 57.5M | 23.0% | 2025-11-12 |
| 2025-09-26 | 13G | Chernett Joreyindividual | 11.4M | 5.0% | 2025-09-22 |
13F holders
Tracked managers holding LCTX at their latest 13F. JSON4 of the 30 tracked managers held LCTX at their latest 13F, $6.3M in total at quarter-end prices. Millennium Management is the largest at $4.0M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 3.0M | $4.0M | 0.00% | -2.5M |
| Renaissance Technologies | 2026-06-30 | 1.3M | $1.8M | 0.00% | -780K |
| Citadel Advisors | 2026-06-30 | 426K | $558K | 0.00% | +295K |
| Two Sigma Investments | 2026-06-30 | 55K | $72K | 0.00% | -34K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Lineage Cell Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Lineage Cell Therapeutics (LCTX), SEC CIK 876343, listed on NYSE, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2025-09-24.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-07-29.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-03-12.JSON and CSV
- Company record
- EDGAR filing index for CIK 876343Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of LCTX is sold short?
25,927,289 shares were held short at the 2026-10-15 settlement, 16.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is LCTX's daily short volume?
On 2026-11-02, 736,224 of the 1,184,529 LCTX shares reported to FINRA were sold short, 62.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does LCTX have fails to deliver?
The SEC's latest file shows 26,826 LCTX shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are LCTX insiders buying or selling?
No open-market insider trades were reported for LCTX in the last 90 days. The most recent filings are listed below. Latest filing: Culley Brian M (President and CEO) on 2026-03-12.
Have LCTX insiders filed to sell?
1 Form 144 notice on file for LCTX worth $96K at the prices reported; 0 in the last 90 days worth $0. Latest: DON M BAILEY filed on 2025-09-24 to sell 60,000 shares ($96K) from 2025-09-24.
Who owns 5% or more of LCTX?
5 holders report 5% or more of LCTX in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is NEAL C. BRADSHER at 23.1% of the class (57,848,357 shares), filed 2025-11-14 for an event on 2025-11-12.
Which tracked 13F managers own LCTX?
4 of the 30 tracked 13F managers held LCTX shares at their latest filing, $6.3M in all. The largest: Izzy Englander's Millennium Management (3.0M shares, $4.0M), Renaissance Technologies (1.3M shares, $1.8M), Ken Griffin's Citadel Advisors (426K shares, $558K), Two Sigma Investments (55K shares, $72K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.